Efficacy of nociceptin inhibition on WDR neuron activity is enhanced in mononeuropathic rats

Brain Research

Volumn 998, Issue 2, 2004, Pages 251-254

  Sotgiu, Maria Luisa ^a   Bellomi, Paola ^a   Biella, Gabriele E M ^a  

^a CNR   (Italy)

Author keywords

CCI rat; Nociceptin; Noxious evoked activity; Wide dynamic range neuron

Indexed keywords

NALOXONE; NOCICEPTIN;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFICACY; EVOKED RESPONSE; MALE; MICROIONTOPHORESIS; MONONEUROPATHY; NERVE CELL; NEUROPATHIC PAIN; NEUROTRANSMISSION; NOCICEPTION; NOCICEPTIVE STIMULATION; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT; SCIATIC NERVE; STIMULUS RESPONSE; WIDE DYNAMIC RANGE NEURON;

EID: 1642575262     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2003.11.025     Document Type: Article

References (22)

1. Bennett G.J., Xie Y.K. A peripheral mononeuropathy in rat produces disorders of pain sensation like those seen in man. Pain. 33:1988;87-107.
2. Briscini L., Corradini L., Ongini E., Bertorelli R. Up-regulation of ORL-1 receptors in spinal tissue of allodynic rats after sciatic nerve injury. Eur. J. Pharmacol. 447:2002;59-65.
3. Carpenter K.J., Vithlani M., Dickenson A.H. Unaltered peripheral excitatory actions of nociceptin contrast with enhanced spinal inhibitory effects after carrageenan inflammation: an electrophysiological study in the rat. Pain. 85:2000;433-441.
4. Diaz A., Dickenson A.H. Blockade of spinal N- and P-type, but not L-type, calcium channels inhibits the excitability of rat dorsal horn neurons produced by subcutaneous formalin inflammation. Pain. 69:1997;93-100.
5. Dickenson A.H. Mechanisms of central hypersensitivity: excitatory amino acid mechanisms and their control. Dickenson A.H., Besson J.M. The Pharmacology of Pain: Handbook of Experimental Pharmacology. 1997;167-196 Springer-Verlag, Heidelberg.
6. Faber E.S., Chambers J.P., Evans R.H., Henderson G. Depression of glutamatergic transmission by nociceptin in the neonatal rat hemisected spinal cord preparation in vitro. Br. J. Pharmacol. 119:1996;189-190.
7. Giuliani S., Maggi C.A. Inhibition of tachykinin release from peripheral endings of sensory nerves by nociceptin, a novel opioid peptide. Br. J. Pharmacol. 118:1996;1567-1569.
8. Hao J.-X., Xu I.S., Wiesenfeld-Hallin Z., Xu X.-J. Anti-hyperalgesic and anti-allodynic effects of intrathecal nociceptin/orphanin FQ in rats after spinal cord injury, peripheral nerve injury and inflammation. Pain. 76:1998;385-393.
9. Hawes B.E., Graziano M.P., Lambert D.G. Cellular actions of nociceptin transduction mechanisms. Peptides. 21:2000;961-967.
10. Lai C.C., Wu S.Y., Dun S.L., Dun N.J. Nociceptin-like immunoreactivity in the dorsal horn and inhibition of substantia gelatinosa neurons. Neuroscience. 81:1997;887-891.
11. Liebel J.T., Swandulla D., Zeilhofer H.U. Modulation of excitatory synaptic transmission by nociceptin in superficial dorsal horn neurons of the neonatal rat spinal cord. Br. J. Pharmacol. 121:1997;425-432.
12. Meunier J.C., Mollereau C., Toll L., Suaudeau C., Moisand C., Alvinerie P., Butour J.L., Guillemot J.C., Ferrara P., Monsarrat B., Mazarguil H., Vassart G., Parmentier M., Constentin G. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature. 377:1995;532-535.
13. Mogil J.S., Pasternak G.W. The molecular and behavioral pharmacology of the orphanin FQ/Nociceptin peptide and receptor family. Pharmacol. Rev. 53:2001;381-415.
14. Neal C.R. Jr., Mansur A., Reincheid R.K., Nothacker H.P., Civelli O., Watson S.J. Jr. Localization of orphanin FQ (nociceptin) peptide and messenger RNA in the central nervous system of the rat. J. Comp. Neurol. 406:1999;503-547.
15. Ozaki S., Kawamoto H., Itoh Y., Miyaji M., Iwasawa Y., Ohta H. A potent and higly selective nonpeptidyl nociceptin/orphanin FQ receptor (ORL1) antagonist: J-113397. Eur. J. Pharmacol. 387:2000;R17-R18.
16. Sotgiu M.L., Biella G. Contribution of central sensitization to the pain-related abnormal activity in neuropathic rats. Somatosens. Motor Res. 17:2000;32-38.
17. Sotgiu M.L., Bellomi P., Biella G. Effect of different concentrations of iontophoretic nociceptin on distinct classes of nociceptive neurons in rat spinal cord. Brain Res. 897:2001;184-187.
18. Stanfa L.C., Chapman V., Kerr N., Dickenson A.H. Inhibitory action of nociceptin on spinal dorsal horn of the rat, in vivo. Br. J. Pharmacol. 118:1996;1875-1877.
19. Wang X.M., Zhang K.M., Long L.O., Mokha S.S. Orphanin FQ (nociceptin) modulates responses of trigeminal neurons evoked by excitatory amino acids and somatosensory stimuli, and blocks the substance P-induced facilitation of N-methyl-D-aspartate-evoked responses. Neuroscience. 93:1999;703-7012.
20. Xu I.S., Grass S., Wiesenfeld-Hallin Z., Xu X.-J. Effects of intrathecal orphanin FQ on a flexor reflex in the rat after inflammation or peripheral nerve section. Eur. J. Pharmacol. 370:1999;17-22.
21. Yamamoto T., Nozaki-Taguchi N., Sakashita Y., Kimura S. Nociceptin/Orphanin FQ: role in nociceptive information processing. Prog. Neurobiol. 57:1999;527-535.
22. Zimmermann M. Ethical guidelines for investigation of experimental pain in conscious animals. Pain. 16:1983;109-110.